FIELD: medicine.
SUBSTANCE: invention concerns a vaccine composition. Characterized vaccine composition contains an effective immunizing amount of inactivated Ehrlichia canis (E. canis), as well as a non-polar solvent, which contains a lipophilic adjuvant, E.canis is inactivated by formalin. Non-polar solvent is a system of chloroform solvents. Invention can be used against monocytic ehrlichiosis in dogs.
EFFECT: at its administering as the primary vaccine in a patient a protective immune response is formed, which is a minimum humoral response.
10 cl, 5 dwg, 18 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INFLUENZA INFECTING DOGS AND USE THEREOF | 2014 |
|
RU2711807C2 |
| CANINE BABESIOSIS VACCINE ANTIGEN | 2011 |
|
RU2599544C2 |
| COMPOSITIONS FOR TREATING AND PREVENTING COMPLEX OF RESPIRATORY DISEASES IN DOGS | 2012 |
|
RU2553222C2 |
| FLU VIRUS, CAPABLE OF INFECTING CANIDAE AND ITS APPLICATION | 2006 |
|
RU2520081C2 |
| HENDRA AND NIPAH VIRUS G GLYCOPROTEIN IMMUNOGENIC COMPOSITIONS | 2012 |
|
RU2681529C2 |
| EHRLICHIA VACCINES AND IMMUNOGENIC COMPOSITIONS | 2020 |
|
RU2824881C2 |
| IMMUNOGENIC COMPOSITIONS OF Bordetella bronchiseptica | 2012 |
|
RU2554480C2 |
| COMPUTER-OPTIMIZED ANTIGENS WITH WIDE REACTIVITY SPECTRUM FOR INFLUENZA VIRUSES OF H5N1 AND H1N1 | 2013 |
|
RU2639551C2 |
| BOVINE VIRAL DIARRHOEA VIRUS TYPE 1B VACCINE COMPOSITIONS AND METHODS FOR PRODUCTION AND USE THEREOF | 2011 |
|
RU2595873C2 |
| VACCINE AGAINST PLAGUE, ADENOVIRUS INFECTIONS, PARVOVIRUS AND CORONAVIRUS ENTERITIS, LEPTOSPIROSIS AND RABIES OF DOGS | 2013 |
|
RU2546247C2 |
